Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients
Condition: Secondary Progressive Multiple Sclerosis Interventions: Drug: Rituximab; Drug: Glatiramer Acetate Sponsor: Isfahan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2017 Category: Research Source Type: clinical trials
Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Active Progressive Multiple Sclerosis Patients
Condition: Progressive Multiple Sclerosis Interventions: Drug: Rituximab; Drug: Glatiramer Acetate Sponsor: Isfahan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2017 Category: Research Source Type: clinical trials
Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients
Condition: Secondary Progressive Multiple Sclerosis Interventions: Drug: Rituximab; Drug: Glatiramer Acetate Sponsor: Isfahan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2017 Category: Research Source Type: clinical trials
Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Active Progressive Multiple Sclerosis Patients
Condition: Progressive Multiple Sclerosis Interventions: Drug: Rituximab; Drug: Glatiramer Acetate Sponsor: Isfahan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2017 Category: Research Source Type: clinical trials
Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) " Prevention of Relapse of Multiple Sclerosis "
Condition: Multiple Sclerosis Intervention: Drug: Glatiramer acetate Sponsor: Takeda Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 4, 2017 Category: Research Source Type: clinical trials
